Supply Constraints Will Restrain Device Demand But Optimism Emerges
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
31 Jul 25
Updated
10 Aug 25
AnalystLowTarget's Fair Value
US$55.00
9.9% undervalued intrinsic discount10 Aug
US$49.56
1Y
14.2%7D
15.9%